Molecular Characterization and Inhibition of Amanitin Uptake into Human Hepatocytes
Open Access
- 22 February 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 91 (1), 140-149
- https://doi.org/10.1093/toxsci/kfj141
Abstract
Amatoxins are the main poison of the green death cap (Amanita phalloides) and among the most dangerous natural toxins causing hepatic failure. A possible therapeutic approach is the inhibition of the transporting systems mediating the uptake of amatoxins into human hepatocytes, which, however, have yet to be identified. In the current study we tested whether members of the organic anion–transporting polypeptide (OATP) family, localized in the sinusoidal membranes of human hepatocytes, are involved in amatoxin uptake. For this, Madin Darby canine kidney strain II (MDCKII) cells stably expressing human OATP1B3, OATP2B1, or OATP1B1, were assayed for the uptake of 3H-labeled O-methyl-dehydroxymethyl-α-amanitin. Under our conditions, only OATP1B3 was able to transport amanitin with a Km value of 3.7μM ± 0.6μM. Accordingly, toxin uptake was inhibited by OATP1B3 substrates and inhibitors (cyclosporin A, rifampicin, the quinoline derivatives MK571 ([(3-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)((3-dimethylamino-3-oxopropyl)thio)methyl)thiopropanoic acid]) and montelukast, the cholecystokinin octapeptide (CCK-8), paclitaxel, and bromosulfophthalein), as well as by some antidotes used in the past for the treatment of human amatoxin poisoning (silibinin dihemisuccinate, penicillin G, prednisolone phosphate, and antamanide). These transport studies are in line with viability assays monitoring the toxic effect of amanitin on the transfected MDCKII cells. Further support for amatoxin transport was found in primary human hepatocytes, expressing OATP1B3, OATP2B1, and OATP1B1, where CCK-8, a substrate specific for OATP1B3, prevented the fragmentation of nucleoli, a lesion typical for amanitin action. In conclusion, we have identified OATP1B3 as the human hepatic uptake transporter for amatoxins; moreover, substrates and inhibitors of OATP1B3, among others rifampicin, may be useful for the treatment of human amatoxin poisoning.Keywords
This publication has 36 references indexed in Scilit:
- Identification of OATP1B3 as a high-affinity hepatocellular transporter of paclitaxelCancer Biology & Therapy, 2005
- Human Hepatobiliary Transport of Organic Anions Analyzed by Quadruple-Transfected CellsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2005
- Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8)Pharmacogenetics, 2004
- Molecular Identification and Characterization of Novel Members of the Human Organic Anion Transporter (OATP) FamilyBiochemical and Biophysical Research Communications, 2000
- Fifty years of amanitinCellular and Molecular Life Sciences, 1991
- Pharmacokinetics and Metabolism of Rifampin in HumansClinical Infectious Diseases, 1983
- THE ACTION OF α-AMANITIN ON RNA SYNTHESIS IN CHINESE HAMSTER OVARY CELLSThe Journal of cell biology, 1974
- Antagonistic effects to phalloidin, α-amanitin and extracts of amanita phalloidesInflammation Research, 1971
- Über die Inhaltsstoffe des grünen Knollenblätterpilzes, XL. Oxydation und Reduktion an der γ.δ‐Dihydroxy‐isoleucin‐Seitenkette des O‐Methyl‐α‐amanitins. Methyl‐aldoamanitin, ein ungiftiges AbbauproduktEuropean Journal of Organic Chemistry, 1970
- α-Amanitin: A specific inhibitor of one of two DNA-dependent RNA polymerase activities from calf thymusBiochemical and Biophysical Research Communications, 1970